Management

Marijana Radonjic

Marijana Radonjic

Marijana is co-founder and CEO of EdgeLeap. As an entrepreneur with a PhD in life sciences, her core expertise is implementation of innovative data science concepts into R&D process of life science industries. From her positions at academia and industry, Marijana has built over a decade-long track record in delivering data science solutions to clients from pharmaceutical, food and healthcare industry. Inspired by endless opportunities to facilitate business by data-driven innovation, Marijana has co-founded EdgeLeap in 2014 – setting out to bring the benefits of data science to all of EdgeLeap’s clients.

Thomas Kelder

Thomas Kelder

Thomas is co-founder and CSO of EdgeLeap. He has a decade-long experience in bioinformatics research, with a focus on network biology, data integration and data visualization. Thomas studied Biomedical Engineering at the Eindhoven University of Technology, followed by a PhD in bioinformatics at Maastricht University. In 2007 he worked as visiting scientist at the Gladstone Institutes in San Francisco where he co-founded and developed WikiPathways. After completion of his thesis, Thomas worked at the Netherlands Organisation for Applied Scientific Research (TNO) where he developed and applied network biology and data integration techniques in projects for pharma and nutrition industry and participated in several EU-funded research projects. Thomas contributed to several leading open source projects in the bioinformatics field and participated in the annual Google Summer of Code projects, both as student and mentor. At EdgeLeap, Thomas combines his experience in and excitement for innovative data science technologies with a hands-on approach to build practical, user-friendly solutions.

Advisory Board

Alain van Gool

Alain van Gool

Alain van Gool is professor Personalized Healthcare at the Radboud university medical center in Nijmegen, The Netherlands, and applied biomarker scientist at TNO (the Netherlands Organisation for Applied Scientific Research), with a strong passion in the application of biomarkers in translational medicine and personalized healthcare.
His professional background since 1991 is a mix of academia, pharmaceutical industry, applied research institutes and university medical centers. He has been leading technology-based biomarker laboratories, cross-functional expert teams, therapeutic project teams and public-private consortia, many of which were focused on the discovery, development and implementation of translational biomarkers in a variety of therapeutic areas. While working in Europe, USA and Asia, he and his teams contributed to over 200 projects in various phases of biomarker R&D.
Alain is a strong believer of open innovation networks, and in his roles he has been collaborating with pharmaceutical, biotechnological, nutriceutical and diagnostic industries, SMEs, biobanks, clinicians, technology providers and information specialists to accelerate applied scientific research through public-private partnerships. His technical expertise resides most strongly in molecular profiling (various Omics approaches), analytical biomarker development, and applications in translational scientific research.
Complementing his daily work, he enjoys contributing to several scientific advisory boards of start-up entrepreneurs, multinational companies, scientific journals and conference organizers.

Alexander Pico

Alexander Pico

Alex is the Executive Director for the National Resource for Network Biology (NRNB), Associate Director of Bioinformatics at Gladstone Institutes in San Francisco, USA, and Vice President of the Cytoscape Consortium. His research focuses on understanding the complex networks that make up biological systems. New technologies continue to drive the amount and diversity of data types that can be analyzed via network analysis. Alex develops software tools and resources that help analyze, visualize and explore biomedical data in the context of these networks. Alex co-founded WikiPathways and coordinates and contributes to a variety of scientific research tools, including GenMAPP-CS and Cytoscape. Alex has received numerous awards and fellowships, including the David Rockefeller Award in 2001, the Howard Hughes Medical Institute Predoctoral Fellowship from 1999-2003, the David and Mary Phillips Distinguished Postdoctoral Fellowship for 2005-2006, and Agilent Technology Foundation Grants from 2006-2008.

Chris Evelo

Chris Evelo

Chris is professor in Bioinformatics for Integrative Systems Biology and leading the Department of Bioinformatics – BiGCaT at Maastricht University, which he started in 2001. His main research interest is in integrative systems biology. By using bioinformatics approaches he integrates experimental data from the genomics and genetics fields with current knowledge, and thus tries to understand the biology behind that data. He is council member of the Nutrigenomics Organization (NuGO), member of the OpenPHACTS steering committee, co-leader of the ELIXIR Interoperability platform. Chris published a total of over 90 papers in the field of bioinformatics, systems biology and toxicology and received the Agilent Thought Leader award in 2011.

Tom Stefels

Tom Stefels

With a background in industrial design and electronics, Tom held various management positions that enabled him to combine his interest in innovation with a keen eye for organization.
During the years in various industries, he learned that the success of product and service innovation strongly depends on how the process of growing the “idea” into sustainable revenues, is managed. Innovation management requires specialists, and Tom decided to found BEACON®, providing these specialists and matching services to leading industry.
Since 2004 Tom has been building and driving a team of 15 professionals in BEACON, offering services from innovation definition to hands-on innovation delivery. The client base of BeaconPartners covers a wide variety of industries and markets, from FMCG multinationals to trend-setting start-ups, from consumer products and services to industrial markets.